key: cord-1021597-5xeiwtwd
authors: Lorencio, C.; Puig, A. Horta; Niell, Á. Castillo; Delgado, A. Timoteo; Torrecilla, N. Ortega; Londoño, J. Gonzalez; Barrero, S. Cuenca
title: Ischemic colitis as a complication of sars-cov-2 pneumonia
date: 2021-12-31
journal: Clinical Nutrition ESPEN
DOI: 10.1016/j.clnesp.2021.09.276
sha: 6f80cf20938d0a93374f3a3f3111e260e1696043
doc_id: 1021597
cord_uid: 5xeiwtwd

nan

Rationale: Gastrointestinal dysfunction (GID) is common in the ICU setting. Up to 60% of patients present some manifestation of DGI during their stay in the ICU. However, an increase in ischemic colitis (IC) has been observed in critically ill patients admitted to the ICU due to ARDS-CoV2 pneumonia. The aim of the study is to present the characteristics of IC in a series of critical patients due to ARDS-CoV-2 pneumonia. Methods: Retrospective analysis of a series of patients admitted to the ICU of a tertiary hospital with SARS-CoV2, that developed IC and required surgery Results: Between March/2020 and January/2021, 287 SARS-CoV2 patients requiring mechanical ventilation were admitted to the ICU of a tertiary hospital. 8 (2'78%) presented gangrenous IC (Brand & Boley) requiring urgent surgery. 87.5% were men, the median age was 60.5 (IR 48.5-71) and the mean BMI was 32.5 (IR: 27-34). 5 patients showed at least one risk factor for IC. The median number of days from intubation to surgery was 13d (IR: 9.5-20.5). Fever (75%) and abdominal distension (62.5%) were the initiall symptoms. The location of the ischemia was the right colon in all cases. 6 patients required extended right hemicolectomy and 2, subtotal colectomies. In the histological study, 7 patients had transmural ischemia, and one patient was limited to the mucosa; predominantly right location was observed. There was no thrombosis or vasculitis in the specimens. Mortality was 37.5% (3/8), due to septic shock and refractory multi-organ failure Conclusion: The incidence of severe IC in critically ill patients due to COVID19 seems higher than that of the overall critically ill patients, without a clear relationship with thromboembolic phenomena in our series. The predominantly right location in all patients could represent an entity of its own secondary to virus infection. Fever and abdominal distension in these patients should lead to suspicion of this entity. Disclosure of Interest: None declared. Rationale: NRS2002 and nutric scores are correlated with poor outcome of COVID-19 critically ill patients. The medical profile with long ICU and ward stay and the altered practical circumstances seen in a pandemic, complicate and challenge nutritional therapy. Although the medical community reacted quickly and nutritional protocols and guidance was foreseen (1), quality of care might be compromised by this healthcare disruption. We aimed to evaluate the adequacy of caloric and protein therapy of COVID-19 patients in the ICU and the following ward stay. Methods: COVID-19 patients with a length of stay of 7 days or more were prospectively followed up until hospital discharge, 8 weeks hospital stay or death. Caloric and protein intake, both intentional and non-intentional was collected and analyzed on a daily basis starting at ICU day 7. Intake was compared to needs, defined by the 2019 ESPEN guideline for clinical nutrition in the ICU: calories guided by indirect calorimetry and protein target defined by 1.3g/kgBW/day in ICU. In the ward the best suited ESPEN guideline (geriatrics, internal medicine) was used. Nutritional therapy adequacy was defined by the ratio intake/needs and expressed in %. Results: Eleven severely ill COVID-19 patients were included, 5 patients died in ICU and one in the ward (in accordance with their calculated mortality risk). Their hospital stay was a mean of 21 days (range 11-32). This represents 171 evaluation days. The mean measured Resting Energy Expenditure was 2079 kcal/day (28 kcal/kg/day) in ICU and 2115 kcal /day in the ward (26 kcal/kg/day). An overall daily intake of 1385 kcal and 70 g of protein was observed. The adequacy of the nutritional therapy was 70% of caloric target and 71% of protein target in the setting of ICU. The same patients, discharged from ICU, had a nutritional adequacy of 50% for calories and 44% for protein in the ward. Conclusion: Caloric targets guided by indirect calorimetry alter with time in a COVID-19 population. Providing adequate amounts of calories and proteins to ICU patients is challenging. The nutritional intake post ICU reveals to be even lower with less than half of recommended proteins being provided in a period of rehabilitation. This iatrogenic malnutrition of COVID-19 ICU survivors needs further investigation and improvement plans. 

Critical Care, Hospital Universitari Arnau de Vilanova, Lleida, Spain; 5 Critical Care

Alcala de Henares, Spain; 15 Critical Care